Norovirus vaccines are showing promise in clinical trials
Early clinical trials indicate that two norovirus vaccines show promise. Moderna’s mRNA-1403 vaccine demonstrated strong antibody responses and safety in adults, while Vaxart’s oral vaccine showed a reduction in norovirus infections but did not meet its primary endpoint. FDA approval… Read More »Norovirus vaccines are showing promise in clinical trials
